β¨ Health Notices
2 AUGUST 2012 NEW ZEALAND GAZETTE, No. 92 2539
Health
Crown Entities Act 2004
New Zealand Public Health and Disability Act 2000
Robert Charles (Bob) Francis
as a member of the Capital & Coast DHB, for a term commencing on 6 August 2012 and ending on 8 December 2013.
Appointment to the Capital & Coast District Health Board (DHB)
Pursuant to the New Zealand Public Health and Disability Act 2000, and the Crown Entities Act 2004, the Minister of Health has appointed
Dated at Wellington this 29th day of July 2012.
HON TONY RYALL, Minister of Health.
go4863
Medicines Act 1981
Renewal of Provisional Consent to the Distribution of Medicines
Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:
Schedule
Product: Fentanyl
Active Ingredient: Fentanyl citrate 15.71mg/L equivalent to fentanyl 10mg/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 23 September 2012.
Product: Fentanyl
Active Ingredient: Fentanyl citrate 31.42mg/L equivalent to fentanyl 20mg/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer: Biomed Limited, Auckland, New Zealand
Note: This renewed consent is valid for two years from 23 September 2012.
Dated this 26th day of July 2012.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go4788
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Primidone
Active Ingredient: Primidone 250mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Ontario, Canada
Product: Creon Micro
Active Ingredient: Pancreatin 60.12mg
Dosage Form: Modified release granules
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Abbott Products GmbH, Neustadt, Germany
Product: Intragam 10 NF
Active Ingredient: Immunoglobulin G 10%w/v
Dosage Form: Solution for infusion
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: CSL Limited, Broadmeadows, Australia
Next Page →
β¨ LLM interpretation of page content
π₯ Appointment to Capital & Coast District Health Board
π₯ Health & Social Welfare29 July 2012
Appointment, District Health Board, Capital & Coast
- Robert Charles (Bob) Francis, Appointed member of Capital & Coast DHB
- HON TONY RYALL, Minister of Health
π₯ Renewal of Provisional Consent to Distribution of Medicines
π₯ Health & Social Welfare26 July 2012
Medicines, Renewal, Fentanyl, Biomed Limited
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π₯ Consent to Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Consent, Apo-Primidone, Creon Micro, Intragam 10 NF
NZ Gazette 2012, No 92